No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Cleo: Confirmation Letter
Cleo: Securities Report - 51st period (April 1, 2023 - March 31, 2024)
Creo: Extraordinary Report
Creo Medical Announces Annual Report and AGM Date
Creo Medical Group (LON:CREO) Shareholders Have Endured a 83% Loss From Investing in the Stock Three Years Ago
Creo Medical Reports Strong Revenue Growth
No Data